Valuation: MedPacto, Inc.

Market Cap 93.23B 67.11M 58.52M 55.25M 50.17M 94.01M 6.44B 94.4M 662M 255M 3.27B 252M 246M 10.53B P/E 2024
-7.42x
P/E 2025 -17.9x
Enterprise Value 54.26B 39.05M 34.05M 32.16M 29.2M 54.71M 3.75B 54.94M 385M 149M 1.91B 147M 143M 6.13B EV / Sales 2024
-
EV / Sales 2025 48,733,025x
Free-Float
74%
Yield 2024 *
-
Yield 2025 -
1 day-6.04%
1 week-1.09%
Current month-2.33%
1 month+11.70%
3 months-19.05%
6 months-48.68%
Current year-59.28%
1 week 2,655
Extreme 2655
3,180
1 month 2,430
Extreme 2430
3,180
Current year 2,235
Extreme 2235
7,980
1 year 2,235
Extreme 2235
8,650
3 years 2,235
Extreme 2235
17,240
5 years 2,235
Extreme 2235
69,600
10 years 2,235
Extreme 2235
134,200
Manager TitleAgeSince
Chief Executive Officer 72 19/06/2013
President 66 28/03/2024
Comptroller/Controller/Auditor 70 28/03/2022
Director TitleAgeSince
Director/Board Member 72 19/06/2013
Director/Board Member 66 28/03/2024
Director/Board Member 64 28/03/2024
Date Insider Type Main position Quantity % Market Cap. Importance
3/4/25 A Buy 10,000 0.0292%
3/4/25 A Buy 10,500 0.0306%
3/4/25 A Buy

Chairperson

15,000 0.0438%
Change 5-day change 1-year change 3-year change Capi.($)
-6.04%-1.09%-40.74%-74.63% 67.11M
-0.31%+5.79%+47.13%+99.00% 70.88B
+0.39%+2.06%+39.38%+78.27% 62.49B
+0.50%+7.13%+33.27%+16.01% 26.34B
-3.21%-7.27%-17.10%+356.10% 26.21B
-2.64%-0.69%-0.17%-13.01% 24.13B
+0.71%+8.03%+25.03%-12.74% 20.72B
+2.12%-5.86%+161.58%+329.34% 15.36B
-0.22%+3.99%+45.54%+172.46% 14.46B
+0.73%+1.71%-5.51%+849.47% 14.24B
Average -0.80%+1.53%+28.84%+180.03% 27.49B
Weighted average by Cap. -0.28%+1.49%+35.66%+148.17%

Financials

2024 2025
Net sales - 3.9K 2.81 2.45 2.31 2.1 3.93 269.27 3.95 27.68 10.68 136.9 10.54 10.31 440.49
Net income -20.14B -14.5M -12.64M -11.94M -10.84M -20.31M -1.39B -20.39M -143M -55.18M -707M -54.46M -53.25M -2.28B -12.81B -9.22M -8.04M -7.59M -6.89M -12.92M -885M -12.97M -90.95M -35.1M -450M -34.64M -33.87M -1.45B
Net Debt -53.54B -38.54M -33.6M -31.73M -28.81M -53.99M -3.7B -54.21M -380M -147M -1.88B -145M -142M -6.05B -38.97B -28.05M -24.46M -23.1M -20.98M -39.3M -2.69B -39.46M -277M -107M -1.37B -105M -103M -4.4B
Logo MedPacto, Inc.
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.
Employees
56
Date Price Change Volume
18/09/26 ₩2,720.00 -6.04% 202,362
17/09/26 ₩2,895.00 +5.27% 147,071
16/09/26 ₩2,750.00 +0.36% 100,943
15/09/26 ₩2,740.00 +0.37% 378,995
14/09/26 ₩2,730.00 -0.73% 57,223
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A235980 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!